Neuralink, the brain-computer interface company founded by Elon Musk, has begun accepting applications for human trials involving its brain implant technology. The trials are open to individuals worldwide with severe disabilities, including quadriplegia, paraplegia, visual impairments, or speech impairments. Applicants must be 18 or older and complete a medical questionnaire. The FDA approved Neuralink’s human testing in September 2023, but only three candidates have previously received implants. Participants will be compensated for travel and study costs. Neuralink aims to address neurological disorders and potentially enhance cognitive abilities in the future. In his statements, Musk emphasized the long-term vision of merging human intelligence with machine capabilities through this technology. The initiative reflects a broader trend in medical technology innovation, particularly for improving the quality of life for individuals with disabilities, while raising ethical and safety concerns regarding brain-computer interfaces.

Source 🔗